Growth Metrics

Evolent Health (EVH) Non-Current Debt (2019 - 2026)

Evolent Health has reported Non-Current Debt over the past 7 years, most recently at $970.5 million for Q4 2025.

  • For Q4 2025, Non-Current Debt rose 97.86% year-over-year to $970.5 million; the TTM value through Dec 2025 reached $970.5 million, up 97.86%, while the annual FY2025 figure was $970.5 million, 97.86% up from the prior year.
  • Non-Current Debt for Q4 2025 was $970.5 million at Evolent Health, down from $1.1 billion in the prior quarter.
  • Over five years, Non-Current Debt peaked at $1.1 billion in Q3 2025 and troughed at $202.1 million in Q1 2021.
  • A 5-year average of $514.9 million and a median of $597.5 million in 2023 define the central range for Non-Current Debt.
  • Biggest five-year swings in Non-Current Debt: fell 18.1% in 2021 and later skyrocketed 123.74% in 2023.
  • Year by year, Non-Current Debt stood at $215.7 million in 2021, then surged by 91.48% to $413.0 million in 2022, then surged by 44.57% to $597.0 million in 2023, then fell by 17.84% to $490.5 million in 2024, then soared by 97.86% to $970.5 million in 2025.
  • Business Quant data shows Non-Current Debt for EVH at $970.5 million in Q4 2025, $1.1 billion in Q3 2025, and $648.5 million in Q2 2025.